External Ventricular Drainage before Endovascular Treatment in Patients with Aneurysmal Subarachnoid Hemorrhage in Acute Period: Its Relation to Hemorrhagic Complications

• Published in: Neurointervention Vol. 14; no. 1; pp. 35 - 42
• Main Authors: Lim, Yong Cheol, Shim, Yu Shik, Oh, Se-Yang, Kim, Myeong Jin, Park, Keun Young, Chung, Joonho
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Society of Interventional Neuroradiology 01-03-2019; 대한신경중재치료의학회
• Subjects: aneurysm, ruptured; hydrocephalus; intracranial aneurysm; Original Paper; subarachnoid hemorrhage; 방사선과학; Hydrocephalus; Subarachnoid hemorrhage; Intracranial aneurysm; Aneurysm, Ruptured
• ISSN: 2093-9043; 2233-6273
• DOI: 10.5469/neuroint.2018.01067

The purpose of this study was to report the authors' experience with external ventricular drainage (EVD) before endovascular treatment (EVT) in patients with acute aneurysmal subarachnoid hemorrhage (aSAH) and to investigate its relation to hemorrhagic complications.
Between March 2010 and December 2017, a total of 122 patients were recruited who had an aSAH, underwent EVT to secure the ruptured aneurysm, and had EVD performed within 72 hours of rupture. The pre-embo EVD group (n=67) comprised patients who underwent EVD before EVT, and the post-embo EVD group (n=55) comprised those who underwent EVD after EVT.
Overall, EVD-related hemorrhage occurred in 18 patients (14.8%): six (8.9%) in the pre-embo EVD group and 12 (21.8%) in the post-embo EVD group (P=0.065). No rebleeding occurred between EVD and EVT in the pre-embo EVD group. Clinical outcomes at discharge did not differ significantly between groups (P=0.384). At discharge, the final modified Rankin Scale score in patients who experienced pre-embo rebleeding was better in the pre-embo EVD group than in the post-embo EVD group (P=0.041). Current use of an antiplatelet agent or anticoagulant on admission (odds ratio [OR], 2.928; 95% confidence interval [CI], 1.234-7.439; P=0.042) and stent use (OR, 2.430; 95% CI, 1.524-7.613; P=0.047) remained independent risk factors for EVD-related hemorrhagic complications.
EVD before EVT in patients with aSAH in acute period did not increase the rate of rebleeding as well as EVD-related hemorrhagic complications. Thus, performing EVD before EVT may be beneficial by normalizing increased intracranial pressure. Especially in patients with rebleeding before the ruptured aneurysm is secured, pre-embo EVD may improve clinical outcomes at discharge.